广西师范大学学报（自然科学版） ›› 2014, Vol. 32 ›› Issue (3): 65-73.

• • 上一篇    下一篇

邻香草醛缩胡椒乙胺席夫碱锌(Ⅱ)配合物的研究

霍红月1,2, 李仲庆1,2, 覃其品1,2, 刘延成1,2, 陈振锋1,2   

  1. 1.广西师范大学化学与药学学院,广西桂林541004;
    2.广西师范大学药用资源化学与药物分子工程国家重点实验室培育基地,广西桂林541004
  • 收稿日期:2014-05-16 出版日期:2014-09-25 发布日期:2018-09-25
  • 通讯作者: 刘延成(1977—),男,河北文安人,广西师范大学副教授,博士;ycliugxnu@aliyun.com
  • 基金资助:
    国家自然科学基金资助项目(21271051,21261025);广西自然科学基金资助项目(2013GXNSFAA019044);药用资源化学与药物分子工程教育部重点实验室基金项目(CMEMR2012-A11,CMEMR2013-C05)

Crystal Structure and Antitumor Activity of Zinc(Ⅱ) Complex with Schiff Bases Derived from 2-Hydroxy-3-methoxybenzaldehyde and 2-(3,4-Methylenedioxyphenyl) ethylamine

HUO Hong-yue1,2, LI Zhong-qing1,2, QIN Qi-pin1,2, LIU Yan-cheng1,2, CHEN Zhen-feng1,2   

  1. 1.College of Chemistry and Pharmaceutical Sciences,Guangxi Normal University, Guilin Guangxi 541004, China;
    2.State Key Laboratory Cultivation Base for the Chemistry and Molecular Engineering of Medicinal Resources, Guangxi Normal University, Guilin Guangxi 541004, China
  • Received:2014-05-16 Online:2014-09-25 Published:2018-09-25

PDF (PC)

166

摘要： 本文以邻香草醛缩胡椒乙胺席夫碱(L)为配体,合成一种新的席夫碱-锌(Ⅱ)双核配合物[Zn2(L)2Cl2](1),并通过谱学分析及X射线单晶衍射分析对配合物1进行结构表征,通过MTT法测试配合物1及L对6种人肿瘤细胞株和人正常肝细胞株HL-7702的体外增殖抑制活性。结果显示,配合物1对所有肿瘤株的增殖抑制率均高于配体,但低于顺铂;对HL-7702,其细胞毒性也远低于顺铂,且略低于配体,表现出一定的细胞毒性选择性。在分子水平上,通过荧光光谱法和凝胶电泳实验研究配合物1及L与DNA的作用机制。结果显示,配合物1以经典插入方式与DNA结合,而L对DNA的插入作用弱,表明柔性配体L与锌(Ⅱ)配位后,芳香平面结构刚性增强,使配合物1对DNA插入作用增强,从而能够通过阻碍肿瘤细胞DNA复制而表现显著高于L的抗肿瘤活性。

关键词: 席夫碱, 锌(Ⅱ)配合物, 晶体结构, 抗肿瘤活性, DNA结合

Abstract: 2-(3,4-Methylenedioxyphenyl)ethylamine and 2-hydroxy-3-methoxybenzaldehyde were selected to synthesize a new Schiff base (L) as bioactive ligand. The reaction of L with ZnCl2·2H2O afforded the binuclear zinc(Ⅱ) complex (1), which was structurally characterized by IR, elemental analysis, ESI-MS, and single crystal X-ray diffraction analysis. The in vitro cytotoxicity of 1against six human tumor cell lines (A549, MDA-MB-231, HeLa229, MGC80-3, A375, BEL-7404) and HL-7702 normal liver cell line was screened by MTT assay. The growth inhibition ratios of 1were found to be higher than those of L against all the tumor cell lines, but lower than those of cisplatin. However, the cytotoxicity of 1against HL-7702 was much lower than those of cisplatin, suggesting the cytotoxic selectivity of 1. On the molecular level, the DNA binding property of 1as well as L was studied by fluorescence spectroscopy and gel electrophoresis assay. The results indicated that complex 1intercalatively bound with DNA, while the intercalative binding ability of L was very weak. It may be ascribed to the much more rigid aromatic planar structure of 1than L, which will facilitate the intercalative binding of 1with DNA to effectively block the DNA replications in tumor cells, and higher antitumor activity of 1can be obtained than L.

Key words: Schiff base, zinc(Ⅱ) complex, crystal structure, antitumor activity, DNA binding

中图分类号: 

  • O641.4
[1] ARGYRIOU A A, ICONOMOU G,KALOFONOS H P. Bortezomib-induced peripheral neuropathy in multiple myeloma:a comprehensive review of the literature[J]. Cancer Treat Rev, 2008, 34:368-377.
[2] MCWHINNEY S R, GOLDBERG R M, MCLEOD H L. Platinum neurotoxicity pharmacogengtics[J].Mol Cancer Ther, 2009, 8:10-16.
[3] POLYANSKAYA T V, KAZHDAN I, MOTLEY D M,et al. Synthesis, characterization and cytotoxicity studies of palladium(Ⅱ)-proflavine complexes[J]. J Inorg Biochem, 2010, 104(11):1205-1213.
[4] ROSU T, PAHONTU E, PASCULESCU S, et al. Synthesis, characterization antibacterial and antiproliferative activity of novel Cu(Ⅱ) and Pd(Ⅱ) complexes with 2-hydroxy-8-R-tricyclo [7.3.1.0.2,7] tridecane-13-one thiosemicarbazone[J]. Eur J Med Chem, 2010, 45(4):1627-1634.
[5] LI Ming-xue, CHEN Chun-ling, ZHANG Dong, et al. Mn(Ⅱ), Co(Ⅱ) and Zn(Ⅱ) complexes with heterocyclic substituted thiosemicarbazones:Synthesis, characterization, X-ray crystal structures and antitumor comparison[J]. Eur J Med Chem, 2010, 45(7):3169-3177.
[6] MARZANO C, PELLEI M, TISATO F, et al. Copper complexes as anticancer agents[J]. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents), 2009, 9(2):185-211.
[7] JIANG Jie, TANG Xiao-liang, DOU Wei, et al. Synthesis and characterization of the ligand based on benzoxazole and its transition metal complexes:DNA-binding and antitumor activity[J]. J Inorg Biochem, 2010, 104(5):583-591.
[8] WANG Rong-min, HE Nai-pu, SONG Peng-fei, et al. Preparation of low-molecular-weight chitosan derivative zinc complexes and their effect on the growth of liver cancer cells in vitro[J]. Pure Appl Chem, 2009, 81(12):2397-2405.
[9] CHELLAIAN J D, JOHNSON J. Spectral characterization, electrochemical and anticancer studies on some metal (Ⅱ) complexes containing tridentate quinoxaline Schiff base[J]. Spectrochim Acta A, 2014, 127:396-404.
[10] 陈思园,杨扬,彭艳,等. 一种新型希夫碱钯配合物晶体结构及抗肿瘤活性研究[J]. 广西师范大学学报:自然科学版, 2013, 31(2):81-86.
[11] Agilent Technologies Inc. CrysAlisPro (Version 1.171.36.28)[CP/CD]. Santa Clara, CA:Agilent Technologies Inc, 2013.
[12] SHELDRICK G M. A short history of SHELX[J]. Acta Cryst, 2008, A64:112-122.
[13] DOLOMANOV O V, BOURHIS L J, GILDEA R J, et al. OLEX2:a complete structure solution, refinement and analysis program[J]. J Appl Cryst, 2009, 42:339-341.
[14] ADAMS H, BAILEY N A, FENTON D E, et al. Zinc(Ⅱ) complexes of tripodal ligands providing phenolate and pyridine donors:formation, structure and hydrolytic activity[J]. J Chem Soc Dalton Trans, 1996:2857-2865
[15] 胡宗球,施少敏,贺红武,等. 一维双核锌配合物[Zn2(SHSH)2(2-Me-py)2]的合成、晶体结构及理论研究[J]. 无机化学学报, 2007, 23(2):323-328.
[16] STREKOWSKI L, WILSON B. Noncovalent interactions with DNA:An overview[J]. Mut Res, 2007, 623:3-13.
[17] PUCCI D, BELLINI T, CRISPINI A, et al.DNA binding and cytotoxicity of fluorescent curcumin-based Zn(Ⅱ) complexes[J]. Med Chem Commun, 2012, 3:462-468.
[18] DENNY W A, FERGUSON L R. Genotoxicity of non-covalent interactions:DNA intercalators[J]. Mut Res, 2007, 623:14-23.
[19] LAKOWICZ J R. Principles of fluorescence spectroscopy[M]. 3rd Ed. Berlin:Springer-Verlag, 2006:278-282.
[20] CHEN Zhen-feng, LIU Yan-cheng, LIU Li-min, et al. Potential new inorganic antitumour agents from combining the anticancer traditional Chinese medicine (TCM) liriodenine with metal ions, and DNA binding studies[J]. Dalton Trans, 2009, 2:262-272.
[1] 谢婷婷, 谢瑶, 倪青玲. 含有机膦金炔三氮唑配合物的合成表征及晶体结构[J]. 广西师范大学学报（自然科学版）, 2020, 38(4): 92-99.
[2] 刘茜. 南方红豆杉提取物的抗氧化、抗肿瘤活性研究[J]. 广西师范大学学报（自然科学版）, 2016, 34(4): 55-59.
[3] 吴亦明, 李亮萍, 曾淑兰, 李晓红, 周祖平, 彭艳. 1,8-萘二甲酰亚胺衍生物NA-17对肝癌细胞株HepG2的体外抗肿瘤作用研究[J]. 广西师范大学学报（自然科学版）, 2016, 34(3): 102-108.
[4] 黄学仁, 赵志愿, 蒋毅民. 4′-(4-苯甲酸)-2,2′:6′,2″-三联吡啶锌配位聚合物的合成、晶体结构及荧光性质研究[J]. 广西师范大学学报（自然科学版）, 2016, 34(2): 98-104.
[5] 王亚娜, 林家皇, 倪青玲, 张芳, 余荣华, 王修建. 2-[1,3-二(2-羟基苯甲基)-5-吡啶基-4-咪唑烷基]苯酚的合成及晶体结构[J]. 广西师范大学学报（自然科学版）, 2016, 34(2): 105-110.
[6] 黄婉云, 殷鹏龙, 李虹, 彭湘艳, 苏桂发. 喹诺酮-二茂铁杂合物的合成及生物活性研究[J]. 广西师范大学学报（自然科学版）, 2016, 34(2): 111-115.
[7] 刘汉甫, 马献力, 陈素一, 沈雪松, 黄富平. 锌三元配合物的合成及其抑菌活性研究[J]. 广西师范大学学报（自然科学版）, 2015, 33(4): 103-107.
[8] 梁晓龙, 黄婉云, 潘成学, 苏桂发. 5-乙酰胺基-4-(4-氯苯基)-2-甲基-6-氧代-5, 6-二氢-4H-吡喃-3-羧酸乙酯的合成及晶体结构[J]. 广西师范大学学报（自然科学版）, 2015, 33(2): 82-87.
[9] 蒋丽萍, 黄婉云, 刘冬成, 梁福沛. 水杨醛联二萘酚二甲酰腙Zn(Ⅱ)、Cu(Ⅱ)配合物的合成及晶体结构[J]. 广西师范大学学报（自然科学版）, 2015, 33(1): 93-98.
[10] 吴睿, 张楠曦, 张潇. 拟卤素化合物Cu[N(CH2OH)2CH2O](SCN)的合成、晶体结构和磁性[J]. 广西师范大学学报（自然科学版）, 2013, 31(4): 78-83.
[11] 曾建强, 梁光明, 黄瑛达, 杨坤国, 桂柳成, 倪青玲. 氢键导向的三维超分子结构{[Co(4,4'-bipy)(H2O)4](pda)2(H2O)2}n的合成及晶体结构(pda-=2-甲基苯并咪唑-1,3-二乙酸根)[J]. 广西师范大学学报（自然科学版）, 2013, 31(2): 69-75.
[12] 陈思园, 杨扬, 彭艳, 刘延成. 一种新型希夫碱钯配合物的晶体结构及抗肿瘤活性研究[J]. 广西师范大学学报（自然科学版）, 2013, 31(2): 81-86.
[13] 张中, 胡坤, 林信良, 孙迎迎. 2-[2-(1H-1,2,4-三氮唑-1-基)乙基]-1H-苯并咪唑水合物的合成、晶体结构及光谱研究[J]. 广西师范大学学报（自然科学版）, 2013, 31(1): 57-61.
[14] 李海叶, 蒋毅民, 蒙秀金. 邻菲咯啉-磺基丙氨酸钴(Ⅱ)配合物的合成与晶体结构[J]. 广西师范大学学报（自然科学版）, 2013, 31(1): 72-75.
[15] 王修建, 丛新宇, 蒋选丰, 马凯, 张子豪, 曾建强, 倪青玲. 由Au…Au键诱导的Au-有机膦一维配位聚合物的合成、结构及表征[J]. 广西师范大学学报（自然科学版）, 2012, 30(3): 189-193.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 广西师范大学学报（自然科学版）编辑部
地址：广西桂林市三里店育才路15号　邮编：541004
电话：0773-5857325　E-mail: gxsdzkb@mailbox.gxnu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发